ChromaDex To Ship Pharmaceutical-Grade Intravenous and Injectable Niagen At Wellness Clinics In August
Portfolio Pulse from Benzinga Newsdesk
ChromaDex will begin shipping pharmaceutical-grade intravenous and injectable Niagen (nicotinamide riboside chloride) to various wellness clinics in August. The distribution will be handled by Wells Pharma of Houston, an FDA-registered 503B outsourcing facility.
July 16, 2024 | 12:39 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
ChromaDex will start shipping pharmaceutical-grade Niagen IV and injections to wellness clinics in August, with distribution managed by Wells Pharma.
The news indicates a significant expansion in ChromaDex's product distribution, which could positively impact revenue and market presence. The involvement of an FDA-registered facility adds credibility and potential for increased demand.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100